Evidence map›Paper›PMID 37268718›Full record

ArticleScientific reports2023

A method for parallel microscale protein labeling and precise control over the average degree of labeling (aDoL).

Qiaoqiao Ruan, Cheng Zhao

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Qiaoqiao RuanApplied Research and Technology, Abbott Diagnostics Division, AP-20, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL, 60064-6016, USA. Qiaoqiao.ruan@abbott.com.
Cheng ZhaoApplied Research and Technology, Abbott Diagnostics Division, AP-20, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL, 60064-6016, USA.
Abbott Fund · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A widely used approach for protein conjugation is through the lysine residues reacting with NHS- or other active esters. However, it is a challenge to precisely control the degree of labeling (DoL) due to the instability of active ester and variability of reaction efficiencies. Here, we provide a protocol for better control of aDoL using existing Copper-free Click Chemistry reagents. It is a two-step reaction with one purification in between. Briefly, proteins of interest were first activated with azide-NHS. After removing unreacted azide-NHS, the protein-N

Indexed as

AzidesProteinsClick ChemistryAzidesProteins

Identifiers

PMID37268718
PMCPMC10238424
OpenAlexW4379197486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.